Reduced skin tumor development in cyclin Dl-deficient mice highlights the oncogenic ras pathway in vivo - Robles, AI; Rodriguez-Puebla, ML; Glick, AB; Trempus, C; Hansen, L; Sicinski, P (Genes Dev., 1998)
et al